Krystal Biotech Total Liabilities (Quarterly) Analysis

Krystal Biotech Inc (KRYS)

182.29 +4.19 (+2.35%) USD | NASDAQ | Nov 21, 16:00

183.99 +1.70 (+0.93%) After-Hours: 06:52

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
September 30, 2024	96.47M
June 30, 2024	78.76M
March 31, 2024	54.05M
December 31, 2023	39.71M
September 30, 2023	34.40M
June 30, 2023	30.91M
March 31, 2023	42.28M
December 31, 2022	36.22M
September 30, 2022	35.61M
June 30, 2022	42.14M
March 31, 2022	68.32M
December 31, 2021	32.72M
September 30, 2021	42.86M
June 30, 2021	25.02M
March 31, 2021	12.37M
December 31, 2020	18.76M

Date	Value
September 30, 2020	9.731M
June 30, 2020	8.449M
March 31, 2020	6.762M
December 31, 2019	6.109M
September 30, 2019	6.586M
June 30, 2019	6.866M
March 31, 2019	6.218M
December 31, 2018	2.89M
September 30, 2018	2.161M
June 30, 2018	0.759M
March 31, 2018	0.452M
December 31, 2017	0.64M
September 30, 2017	2.475M
June 30, 2017	0.584M
December 31, 2016	1.893M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

6.109M

Minimum

Dec 2019

96.47M

Maximum

Sep 2024

36.08M

Average

35.00M

Median

Total Liabilities (Quarterly) Benchmarks

Bioventus Inc	582.66M
ADMA Biologics Inc	158.73M
Alnylam Pharmaceuticals Inc	4.173B
Amicus Therapeutics Inc	607.73M
Rhythm Pharmaceuticals Inc	352.36M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly)	982.32M
Shareholders Equity (Quarterly)	885.85M
Current Ratio	7.966